FSPHX
Price
$30.88
Change
-$0.61 (-1.94%)
Updated
Nov 14 closing price
LHCOX
Price
$20.86
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FSPHX vs LHCOX

Header iconFSPHX vs LHCOX Comparison
Open Charts FSPHX vs LHCOXBanner chart's image
Fidelity Select Health Care
Price$30.88
Change-$0.61 (-1.94%)
VolumeN/A
CapitalizationN/A
Lord Abbett Health Care F3
Price$20.86
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSPHX vs LHCOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. LHCOX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a StrongSell and LHCOX is a Buy.

FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 7.41B vs. LHCOX (8.9M). FSPHX (0.00) and LHCOX (0.00) have matching dividends . FSPHX was incepted earlier than LHCOX: FSPHX (43 years) vs LHCOX (5 years). LHCOX is a more actively managed with annual turnover of: 74.00 vs. FSPHX (40.00). FSPHX (0) and LHCOX (0) have matching initial minimum investment requirements. LHCOX annual gain was more profitable for investors over the last year : 28.82 vs. FSPHX (21.16). LHCOX return over 5 years is better than : 37.13 vs. FSPHX (19.77).
FSPHXLHCOXFSPHX / LHCOX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence43 years5 years-
Gain YTD9.49214.95663%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets7.41B8.9M83,296%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.1628.8273%
Returns for 3 years-8.78-4.05217%
Returns for 5 years19.7737.1353%
Returns for 10 years40.44N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIELX8.45N/A
N/A
MassMutual International Eq Adm
DSEFX39.72N/A
N/A
Domini Impact Equity Investor
JGLYX19.28N/A
N/A
JPMorgan Small Cap Growth R4
RFEBX87.35-0.26
-0.30%
American Funds Fundamental Invs R2E
DGECX19.84-0.13
-0.65%
BNY Mellon Global Emerging Mkts - C